Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
RESEARCH TOOLSreports
Holding MRSN?
Track your performance easily
See the Price Targets and Ratings of:
MRSN Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MRSN Stock 12 Month Forecast
Average Price Target
$6.33
▲(210.29% Upside)
| Highest Price Target$8.00 | Average Price Target$6.33 | Lowest Price Target$5.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Reiterated
11/14/24
BTIG
Reiterated
11/13/24
TD Cowen
Reiterated
11/13/24
LifeSci Capital
Reiterated
11/13/24
Leerink Partners
$7
Buy
243.14%
Upside
Reiterated
08/13/24
We continue to believe that investor focus remains on MRSN's lead and view the presentation of initial Phase I data later this year as the next catalyst for the stock. Overall, we remain OP-rated at current stock levels and believe XMT-1660 represents a reasonable shot on goal. Reiterate OP.
Robert W. Baird
$3
Hold
47.06%
Upside
Reiterated
08/13/24
Analysts Conflicted on These Healthcare Names: MiNK Therapeutics (NASDAQ: INKT), Silence Therapeutics (NASDAQ: SLN) and Mersana Therapeutics (NASDAQ: MRSN)
J.P. Morgan
$5
Hold
145.10%
Upside
Upgraded
03/19/24
Mersana Therapeutics upgraded to Neutral from Underweight at JPMorganMersana Therapeutics upgraded to Neutral from Underweight at JPMorgan
Wedbush
$2→$7
Buy
243.14%
Upside
Upgraded
02/29/24
Mersana Therapeutics upgraded to Outperform from Neutral at WedbushMersana Therapeutics upgraded to Outperform from Neutral at Wedbush
Guggenheim
$7
Buy
243.14%
Upside
Upgraded
02/28/24
Mersana Therapeutics upgraded to Buy from Neutral at GuggenheimMersana Therapeutics upgraded to Buy from Neutral at Guggenheim
Best Analysts Covering Mersana Therapeutics
Which Analyst Should I Follow If I Want to Buy MRSN and Sell After:
1 Month
xxx
Success Rate
14/26 ratings generated profit
Average Return
+1.52%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.85% of your transactions generating a profit, with an average return of +1.52% per trade.
3 Months
xxx
Success Rate
7/26 ratings generated profit
Average Return
+5.25%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 26.92% of your transactions generating a profit, with an average return of +5.25% per trade.
1 Year
Success Rate
4/12 ratings generated profit
Average Return
-4.32%
upgraded a buy rating 9 months ago
Copying David Nierengarten's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -4.32% per trade.
2 Years
xxx
Success Rate
2/9 ratings generated profit
Average Return
-28.21%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -28.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MRSN Analyst Recommendation Trends
Rating
May 24
Jul 24
Aug 24
Sep 24
Nov 24
Strong Buy
4
4
7
8
10
Buy
6
1
3
4
6
Hold
3
2
2
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
7
12
13
17
Each month's total comprises the sum of three months' worth of ratings.
MRSN Financial Forecast
MRSN Stock Forecast FAQ
What is MRSN’s average 12-month price target, according to analysts?
Based on analyst ratings, Mersana Therapeutics Inc’s 12-month average price target is $6.33.
What is MRSN’s upside potential, based on the analysts’ average price target?
Mersana Therapeutics Inc has 210.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MRSN a Buy, Sell or Hold?
Mersana Therapeutics Inc has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Mersana Therapeutics Inc’s price target?
The average price target for Mersana Therapeutics Inc is $6.33. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.00 ,the lowest forecast is $5.00. The average price target represents 210.29% Increase from the current price of $2.04.
The highest analyst price target is $8.00 ,the lowest forecast is $5.00. The average price target represents 210.29% Increase from the current price of $2.04.
What do analysts say about Mersana Therapeutics Inc?
Mersana Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of MRSN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.